M. Ahn, Soon Sun Kim, Tae-Ho Kim, S. Han, D. Kim, Hugh C. Kim, Se-Hyuk Kim, J. Han, Ho Sung Kim, Y. Chung
{"title":"A Case of Panhypopituitarism and Central Diabetes Insipidus Caused by Primary Central Nervous System Lymphoma","authors":"M. Ahn, Soon Sun Kim, Tae-Ho Kim, S. Han, D. Kim, Hugh C. Kim, Se-Hyuk Kim, J. Han, Ho Sung Kim, Y. Chung","doi":"10.3803/JKES.2008.23.4.260","DOIUrl":null,"url":null,"abstract":"Primary central nervous system (CNS) lymphoma is an uncommon neoplasm. However, the incidence of primary CNS lymphoma has increased more than 10-fold over the past three decades, and continues to accelerate. Currently, primary CNS lymphoma represents 4 to 7 percent of all newly diagnosed primary CNS tumors. Primary CNS lymphoma may arise from different parts of the brain, with deep hemispheric periventricular white matter being the most common site of origin. The presenting symptoms in primary CNS lymphoma vary depending on the location of the mass. Involvement of the hypothalamic-pituitary axis may cause hypopituitarism, diabetes insipidus, headache, diplopia, and blurred vision. We experienced a case of a 58-year-old woman who developed central diabetes insipidus and panhypopituitarism secondary to primary CNS lymphoma. Hypothalamic and thalamic involvement were suspected based on brain MRI, and primary CNS lymphoma was confirmed by a CT-guided stereotactic biopsy. Through performing a water deprivation test and a combined pituitary stimulation test, we diagnosed complete type central diabetes insipidus and panhypopituitarism. Symptomatic relief was obtained with desmopressin, levothyroxine, hydrocortisone, and high-dose methotrexate-based chemotherapy. The thalamic and hypothalamic masses were significantly decreased in size after chemotherapy. We report the details of this case along with a review of the literature concerning primary CNS lymphom (J Korean Endocr Soc 23:260~265, 2008)","PeriodicalId":119859,"journal":{"name":"Journal of Korean Endocrine Society","volume":"11 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2008-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Korean Endocrine Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3803/JKES.2008.23.4.260","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Primary central nervous system (CNS) lymphoma is an uncommon neoplasm. However, the incidence of primary CNS lymphoma has increased more than 10-fold over the past three decades, and continues to accelerate. Currently, primary CNS lymphoma represents 4 to 7 percent of all newly diagnosed primary CNS tumors. Primary CNS lymphoma may arise from different parts of the brain, with deep hemispheric periventricular white matter being the most common site of origin. The presenting symptoms in primary CNS lymphoma vary depending on the location of the mass. Involvement of the hypothalamic-pituitary axis may cause hypopituitarism, diabetes insipidus, headache, diplopia, and blurred vision. We experienced a case of a 58-year-old woman who developed central diabetes insipidus and panhypopituitarism secondary to primary CNS lymphoma. Hypothalamic and thalamic involvement were suspected based on brain MRI, and primary CNS lymphoma was confirmed by a CT-guided stereotactic biopsy. Through performing a water deprivation test and a combined pituitary stimulation test, we diagnosed complete type central diabetes insipidus and panhypopituitarism. Symptomatic relief was obtained with desmopressin, levothyroxine, hydrocortisone, and high-dose methotrexate-based chemotherapy. The thalamic and hypothalamic masses were significantly decreased in size after chemotherapy. We report the details of this case along with a review of the literature concerning primary CNS lymphom (J Korean Endocr Soc 23:260~265, 2008)
原发性中枢神经系统淋巴瘤是一种罕见的肿瘤。然而,原发性中枢神经系统淋巴瘤的发病率在过去三十年中增加了10倍以上,并且还在继续加速。目前,原发性中枢神经系统淋巴瘤占所有新诊断的原发性中枢神经系统肿瘤的4%至7%。原发性中枢神经系统淋巴瘤可发生于大脑的不同部位,以深部半球脑室周围白质为最常见的起源部位。原发性中枢神经系统淋巴瘤的症状因肿块的位置而异。下丘脑-垂体轴受累可引起垂体功能减退、尿崩症、头痛、复视和视力模糊。我们经历了一个58岁的女性,她发展为中枢性尿囊症和垂体功能减退,继发于原发性中枢神经系统淋巴瘤。颅脑MRI怀疑下丘脑和丘脑受累,ct引导立体定向活检证实原发性中枢神经系统淋巴瘤。通过缺水试验和联合垂体刺激试验,我们诊断为完全型中枢性尿囊症和全垂体功能低下症。去氨加压素、左甲状腺素、氢化可的松和大剂量甲氨蝶呤化疗均可缓解症状。化疗后丘脑和下丘脑肿块明显减小。我们报告了这个病例的细节,并回顾了有关原发性中枢神经系统淋巴的文献(J Korean endocsoc23:260~265, 2008)。